Navigation Links
Allegheny General Hospital Performs First Liver Transplant

28 year-old Mother of Three Recovering Well After November 1 Procedure

PITTSBURGH, Pa., Nov. 15 /PRNewswire/ -- A 28 year-old Robinson Township woman has become the first patient to undergo liver transplantation surgery at Allegheny General Hospital (AGH).

AGH officials said the surgery, which took place on November 1, represents a milestone locally in the field of organ transplantation, providing end stage liver disease patients with a vital, new choice for surgical care.

"This program is a critical new resource for liver transplantation candidates in western Pennsylvania and the tri-state region, particularly those who have traditionally been referred out of state for surgery due to lack of access to a local transplant center. Though recently established, it affords patients access to a surgical team whose skill and experience rivals most in the nation," said Mark Roh, M.D., chairman of AGH's Department of Surgery.

Christine Berman was admitted to AGH on October 28 suffering from a sudden onset of acute liver disease called fulminant hepatic failure. An often rapidly fatal condition, she was immediately placed on the transplant list as a status 1A candidate and underwent liver transplantation surgery three days later.

The surgery was performed by Thomas V. Cacciarelli, M.D., director of Liver Transplantation at AGH, and Dr. Roh.

After the six-hour operation and a week in AGH's surgical intensive care unit, Berman 's new liver is functioning perfectly well, Dr. Cacciarelli said.

The mother of three young children, Berman said she and her family are most grateful for the care she received at AGH and for the availability of the donor organ that saved her life.

"I am alive today because of this hospital, because of these wonderful doctors and nurses and everyone else involved in the transplant program, and most importantly, because of the gift of life that was bestowed to me from an organ donor and their family. My children still have a mother because of all of these special people," Berman said.

Dr. Cacciarelli said Berman will now receive the standard post-transplant care regimen, including continuous monitoring of her liver function and for a period of time weekly visits to AGH's transplant clinic for routine diagnostic follow up.

"The success of Christine's surgery underscores the impressive level of expertise and sophistication that this program brings to the community. The severity of her liver disease was such that a multi disciplinary team approach was necessary for a successful outcome," said Dr. Cacciarelli.

The AGH team performed its second liver transplant on November 8. That patient too is recovering well, Dr. Cacciarelli said.

According to UNOS, more than 17,000 people in the U.S. are on the waiting list for liver transplantation, including approximately 2,537 people combined from the region that includes the states of Pennsylvania, Ohio and West Virginia.

UNOS data also shows that the demand for liver transplantation has been steadily increasing over the past five years.

Other key members of the AGH Liver Transplantation Program include Michael Dishart, M.D., chief anesthesiologist, Bryan Veynovich, M.D., critical care medicine and Jose Oliva, M.D., hepatologist and medical director of the program.

Paul Lebovitz, M.D., director of AGH's Division of Gastroenterology said that adding liver transplantation to the spectrum of advanced therapies for hepatic disease already offered at the hospital is an important step forward for AGH and for the region.

Under Dr. Lebovitz's direction, AGH's gastroenterology practice is the second largest program in western Pennsylvania and annually refers 20 to 30 patients to other hospitals for liver transplantation evaluation.

"The last thing a very sick patient needs at the most critical point in their disease management is to be sent to a healthcare facility and into the care of a medical staff that they are unfamiliar with. That hardship is particularly exacerbated when the new facility is hundreds of miles away in another state," said Dr. Lebovitz.

"Our program for the treatment of liver disease is among the most advanced in the country. Given that we provide the highest level of care for patients with end stage liver disease preoperatively and postoperatively, the ability to now meet their transplantation surgical needs is a tremendous advantage," Dr. Lebovitz said.

SOURCE Allegheny General Hospital
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. General Wesley Clark Joins Immtech as Consulting Strategic Advisor
2. Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinsons Disease
3. Sugammadex Trials Demonstrate Rapid Recovery from Profound Neuromuscular Blockade During General Anesthesia
4. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
5. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
6. Gilbert Hospital Continues Cutting Edge Treatments
7. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
8. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
9. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
10. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
11. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
Post Your Comments:
(Date:6/26/2016)... of Australia,s successful biotechnology scientists, Dr ... company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm is ... the ASX. Noxopharm is a clinic-ready company with its ... clinical study later this year. ... facing cancer patients - the ability of cancers to become resistant ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, ... work on several important health care topics including advance care planning, healthcare costs ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... 2016 , ... Marcy was in a crisis. Her son James, eight, was out of control. ... and physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. ... rocks at my other children and say he was going to kill them. If ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
Breaking Medicine News(10 mins):